HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dan He Selected Research

Fibroblast Growth Factor 8

10/2013A short peptide derived from the gN helix domain of FGF8b suppresses the growth of human prostate cancer cells.
5/2013Screening a phage display library for a novel FGF8b-binding peptide with anti-tumor effect on prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dan He Research Topics

Disease

57Neoplasms (Cancer)
05/2022 - 05/2004
9Ischemic Stroke
07/2022 - 06/2012
9Neoplasm Metastasis (Metastasis)
02/2022 - 12/2008
8Carcinogenesis
01/2022 - 12/2008
7Hyperuricemia
12/2021 - 09/2015
7Hypoxia (Hypoxemia)
01/2019 - 06/2014
7Carcinoma (Carcinomatosis)
12/2017 - 11/2003
6Stroke (Strokes)
07/2022 - 06/2012
6Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 12/2014
6Prostatic Neoplasms (Prostate Cancer)
01/2022 - 09/2010
6Atherosclerosis
11/2021 - 05/2015
6Type 2 Diabetes Mellitus (MODY)
10/2021 - 01/2014
6Stomach Neoplasms (Stomach Cancer)
01/2021 - 11/2013
6Infections
12/2020 - 09/2013
5Breast Neoplasms (Breast Cancer)
03/2022 - 02/2016
4Adenocarcinoma of Lung
04/2021 - 01/2018
4Lung Neoplasms (Lung Cancer)
01/2021 - 11/2018
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2019 - 04/2015
4Spinal Tuberculosis (Pott's Disease)
01/2018 - 01/2014
3Inflammation (Inflammations)
01/2022 - 01/2020
3COVID-19
01/2022 - 01/2021
3Alzheimer Disease (Alzheimer's Disease)
04/2021 - 06/2012
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 04/2020
3Virus Diseases (Viral Diseases)
01/2021 - 01/2015
3Rheumatoid Arthritis
04/2019 - 06/2012
3Cardiovascular Diseases (Cardiovascular Disease)
11/2016 - 04/2015
3B-Cell Lymphoma (Lymphoma, B Cell)
12/2015 - 06/2014
3Infarction (Infarctions)
11/2014 - 06/2012
2Metabolic Diseases (Metabolic Disease)
08/2022 - 12/2021
2Squamous Cell Carcinoma of Head and Neck
01/2022 - 10/2013
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2020
2Adenocarcinoma
01/2022 - 01/2021
2Hypertension (High Blood Pressure)
12/2021 - 10/2021
2Disease Progression
10/2021 - 04/2012
2Anemia
11/2020 - 01/2020
2Papillomavirus Infections
10/2020 - 01/2015
2Retinoblastoma (Glioblastoma, Retinal)
10/2020 - 01/2015
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2020 - 01/2019
2Pathologic Processes
01/2020 - 01/2018
2Necrosis
01/2020 - 11/2014

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
03/2022 - 11/2003
10Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2010
8Polysaccharides (Glycans)IBA
08/2022 - 06/2014
7EnzymesIBA
07/2020 - 09/2015
6CurcuminIBA
01/2021 - 01/2015
6RNA (Ribonucleic Acid)IBA
11/2020 - 04/2012
6Messenger RNA (mRNA)IBA
10/2020 - 06/2014
6Biological ProductsIBA
05/2019 - 09/2004
5Small Interfering RNA (siRNA)IBA
01/2022 - 07/2010
5LipidsIBA
10/2021 - 04/2014
5DNA (Deoxyribonucleic Acid)IBA
10/2019 - 10/2006
5Neuroprotective AgentsIBA
01/2018 - 07/2012
4Peptides (Polypeptides)IBA
03/2022 - 05/2013
4oxidized low density lipoproteinIBA
11/2021 - 05/2015
4Glucose (Dextrose)FDA LinkGeneric
10/2021 - 08/2015
4Pharmaceutical PreparationsIBA
01/2021 - 03/2013
4Urate Oxidase (Uricase)IBA
07/2020 - 01/2016
4Long Noncoding RNAIBA
01/2020 - 06/2016
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
07/2022 - 01/2021
3Uric Acid (Urate)IBA
12/2021 - 09/2015
3Protein Isoforms (Isoforms)IBA
04/2021 - 05/2013
3CytokinesIBA
11/2020 - 01/2019
3Matrix Metalloproteinases (MMPs)IBA
08/2020 - 12/2008
3MicroRNAs (MicroRNA)IBA
11/2019 - 01/2017
3Oxygen (Dioxygen)IBA
01/2019 - 07/2016
3NF-kappa B (NF-kB)IBA
01/2019 - 04/2002
3Therapeutic UsesIBA
01/2018 - 03/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 05/2015
3HDL LipoproteinsIBA
04/2016 - 01/2014
3Caspase 3 (Caspase-3)IBA
12/2015 - 06/2014
2HydrogelsIBA
03/2022 - 01/2022
2Tumor Biomarkers (Tumor Markers)IBA
02/2022 - 01/2022
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 12/2021
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2017
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2022 - 01/2012
2Apolipoproteins E (ApoE)IBA
11/2021 - 05/2015
2InflammasomesIBA
11/2021 - 05/2015
2Linoleic Acid (Linoleate)IBA
10/2021 - 01/2020
2LuciferasesIBA
01/2021 - 04/2015
2AntibodiesIBA
01/2021 - 01/2020
2AntigensIBA
01/2021 - 05/2004
2Cyclin B1IBA
10/2020 - 07/2017
2PlatinumIBA
08/2020 - 09/2017
2Sirolimus (Rapamycin)FDA Link
07/2020 - 01/2019
2N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA
07/2020 - 01/2019
2Proliferating Cell Nuclear Antigen (PCNA)IBA
05/2020 - 05/2013
2ChitosanIBA
04/2020 - 07/2016
2Streptozocin (Streptozotocin)FDA Link
03/2020 - 01/2020
2Oncogene Proteins (Oncogene Protein)IBA
01/2020 - 01/2015
2Chemokine CXCL16IBA
01/2020 - 01/2018

Therapy/Procedure

21Therapeutics
07/2022 - 09/2004
5Drug Therapy (Chemotherapy)
05/2022 - 09/2015
5Radiotherapy
02/2022 - 01/2019
5Length of Stay
01/2021 - 08/2010
5Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2020 - 06/2014
3Oral Administration
10/2020 - 01/2020
2Injections
03/2022 - 01/2022
2Immunotherapy
01/2021 - 01/2021
2Precision Medicine
01/2021 - 01/2018
2Aftercare (After-Treatment)
05/2020 - 01/2018